Welcome to CDC stacks | Licensure of a diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus, and haemophilus B conjugate vaccine and guidance for use in infants and children - 7435 | Guidelines and Recommendations
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Licensure of a diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus, and haemophilus B conjugate vaccine and guidance for use in infants and children
Filetype[PDF-1.60 MB]


Details:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. Coming Soon
    Timeline of Advisory Committee on Immunization Practices (ACIP) recommendations for diphtheria and tetanus toxoids and acellular pertussis vaccines (DTaP) and tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap), 1991 – 2015 : supplementary figures for: Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.); United States. Advisory Committee on Immunization Practices.;
    Published:
    April 27, 2018
    Source:
    Liange JL, Tiwari T, Moro P, Messonnier NE, Reingold A, Sawyer M, Clark TA. MMWR Surveill Summ 2018;67(No. RR-2).
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 67, no. RR2
    Public Access
    Available on:
    April 26, 2018
  2. Licensure of a diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine and guidance for use as a booster dose
    Published:
    October 3, 2008
    Source:
    MMWR. Morbidity and mortality weekly report. 2008; 57(39):1078-9.
    Description:
    On June 24, 2008, the Food and Drug Administration licensed a combined diphtheria and tetanus toxoids and acellular pertussis adsorbed (DTaP) and inactivated poliovirus (IPV) vaccine, DTaP-IPV (Kinrix, GlaxoSmithKline Biologicals, Rixensart, Belgium)...
    Status:
    superseded
    File Type:
    Filetype[PDF - 1.60 MB]
  3. MMWR. Morbidity and mortality weekly report, Vol. 57, no. 39, October 3, 2008
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.)
    Published:
    October 3, 2008
    Series:
    MMWR. Morbidity and mortality weekly report ; v. 57, no. 39
    Description:
    Racial/Ethnic Disparities in Self-Rated Health Status Among Adults With and Without Disabilities - United States, 2004 - 2006 -- HIV Prevalence Estimates - United States, 2006 -- Rabies in a Dog Imported from Iraq - New Jersey, June 2008 -- Licensure...
    File Type:
    Filetype[PDF - 1.60 MB]
  4. Pertussis vaccination : use of acellular pertussis vaccines among infants and young children : recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Personal Author:
    Guris, Dalya; Strebel, Peter M.; Jafari, Hamid; Wharton, Melinda; Hadler, Stephen C.;
    Corporate Author:
    United States. Advisory Committee on Immunization Practices.; National Immunization Program (Centers for Disease Control and Prevention)‏;
    Published:
    March 28, 1997
    Source:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 1997; 46(RR-7):1-25.
    Description:
    Concerns about the safety of whole-cell pertussis vaccines prompted development of acellular vaccines that are less likely to provoke adverse events because they contain purified antigenic components of Bordetella pertussis. Two diphtheria and tetanu...
    Status:
    current
    File Type:
    Filetype[PDF - 317.63 KB]
  5. Surveillance for safety after immunization; vaccine adverse event reporting system (VAERS) - United States 1991-2001
    Personal Author:
    Ball, Robert; Braun, M. Miles; Chen, Robert T.; Ellenberg , Susan S.; English-Bullard, Roseanne; Haber, Penina; Iskander, John K.; Mootrey, Gina T.; Pless, Robert P.; Pool, Vitali; Wise, Robert P.; Zhou, Weigong;
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.)
    Published:
    January 24, 2003
    Series:
    MWWR. Surveillance summaries : Morbidity and mortality weekly report. Surveillance summaries ; 52, no. 1
    Description:
    PROBLEM/CONDITION: Vaccines are usually administered to healthy persons who have substantial expectations for the safety of the vaccines. Adverse events after vaccinations occur but are generally rare. Some adverse events are unlikely to be detected ...
    File Type:
    Filetype[PDF - 272.27 KB]